Back
Zentalis Pharmaceuticals Stock Predictions
Pacaso has reserved the Nasdaq ticker PCSO and is offering shares at just $2.80 - but only until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Sell
32
ZNTL
Zentalis Pharmaceuticals
Last Price:
$1.20
Seasonality Move:
-15.96%
7 Day Trial
ALL ACCESS PASS
$
7
Disrupting a Trillion-Dollar Industry
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.Zentalis Pharmaceuticals Stock Forecast
-
Is Zentalis Pharmaceuticals Stock Undervalued?The current Zentalis Pharmaceuticals [ZNTL] share price is $1.20. The Score for ZNTL is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
ZNTL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Zentalis Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
Zentalis Pharmaceuticals Stock Rating
Data Unavailable
Zentalis Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
zentalis.com
52-Week Data
52-Week High:
13.00
52-Week Low:
1.01
Prediction Charts
Market Cap:
86.3M
Price in USD:
1.20
Volume:
778.3K
Beta:
1.67
Technical Analysis
SMA50:
1.42
SMA100:
1.84
SMA200:
2.59
52-Wk Change:
-89.36%
Stock Predictions
-
Is Zentalis Pharmaceuticals stock public?Yes, Zentalis Pharmaceuticals is a publicly traded company.
-
What is the Zentalis Pharmaceuticals stock quote today?The Zentalis Pharmaceuticals stock price is 1.20 USD today.
-
How to buy Zentalis Pharmaceuticals stock online?You can buy Zentalis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-6 | 1.32 | 1.25 | 1.33 | 1.23 |
| May-7 | 1.25 | 1.23 | 1.27 | 1.20 |
| May-8 | 1.23 | 1.26 | 1.32 | 1.20 |
| May-9 | 1.24 | 1.23 | 1.30 | 1.20 |
| May-12 | 1.27 | 1.29 | 1.33 | 1.25 |
| May-13 | 1.30 | 1.21 | 1.30 | 1.21 |
| May-14 | 1.21 | 1.19 | 1.24 | 1.17 |
| May-15 | 1.24 | 1.26 | 1.26 | 1.16 |
| May-16 | 1.26 | 1.26 | 1.27 | 1.23 |
| May-19 | 1.24 | 1.25 | 1.29 | 1.21 |
| May-20 | 1.23 | 1.28 | 1.31 | 1.22 |
| May-21 | 1.28 | 1.21 | 1.29 | 1.20 |
| May-22 | 1.20 | 1.24 | 1.24 | 1.18 |
| May-23 | 1.22 | 1.20 | 1.22 | 1.19 |
Zentalis Pharmaceuticals Earnings
Data Unavailable
Zentalis Pharmaceuticals Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.15 per share, an increase this year of $0.19 per share, and an increase next year of $0.16 per share.
* Zentalis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.